Clinical trial
Effect of Incentive Spirometery on Asthmatic Pregnant Women
Name
Eman_Amin_2023
Description
The purpose of this study is to determine the effect of the incentive spirometer on asthma during pregnancy.
Trial arms
Trial start
2020-09-20
Estimated PCD
2021-09-15
Trial end
2022-02-15
Status
Completed
Treatment
pulmicort inhaler
Each woman in both groups (A\&B) will receive pulmicort inhaler on needs.
Arms:
incentive spirometer, pulmicort inhaler
Incentive spirometer treatment
Each patient in group B will be instructed about the effects of incentive spirometer to gain their cooperation during the study course.
Arms:
incentive spirometer
Size
60
Primary endpoint
Assessing the change in lung functions
at baseline and after 6 weeks of intervention
Assessing the change in symptoms of asthma
at baseline and after 6 weeks of intervention
Eligibility criteria
Inclusion Criteria:
The patients will have the following criteria:
1. Their age will range from 30 to40years old.
2. Body mass index (BMI) will range from 25-29.9 kg/m2.
3. All patients will be clinically and medically stable.
Exclusion Criteria:
Patients will be excluded from the study if they have the following:
1. Diabetes mellitus.
2. Severe hypertension.
3. Neurological and neuromuscular disorders.
4. Blindness.
5. Developed moderate and severe degree of pleural effusion.
6. Cardiovascular instability.
7. Chronic chest disease.
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'DOUBLE', 'whoMasked': ['PARTICIPANT', 'INVESTIGATOR']}}, 'enrollmentInfo': {'count': 60, 'type': 'ACTUAL'}}
Updated at
2023-06-15
1 organization
1 product
2 indications
Organization
Cairo UniversityProduct
PulmicortIndication
AsthmaIndication
Pregnancy Complications